Intuitive Surgical upgraded to Buy from Neutral at Goldman Goldman upgraded Intuitive Surgical and believes general surgery uptake will be the next leg of growth as surgical robotics evolves. The firm said the new da Vinci, upgrades, and add-ons will accelerate growth and that there is potential for management to return excess cash to shareholders. Price target raised to $715 from $591.
News For ISRG From The Last 14 Days
Check below for free stories on ISRG the last two weeks.